Trial Details

TERMINATED
Basic Information
Clinical ID c2603
Identifier NCT03232580
Trial Title 99mTc-rhAnnexin V-128 in Diagnosis of Spondyloarthritis
Trial URL Visit Original Page
Study Information
Study Results

YES

Conditions Spondyloarthritis
Interventions DRUG: rhAnnexin V-128
Participant Information
Sponsor Advanced Accelerator Applications
City Los Angeles
Country/Region United States
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE2
Time Information
Start Date 2017-09-18
Primary Completion Date 2018-11-12
Completion Date 2018-11-12